Related Experiment Video

Updated: Oct 14, 2025

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

10.5K

Single-Dose Ad26.COV2.S Vaccine-Room for Improvement

Zahra Rikhtegaran Tehrani1, Mohammad M Sajadi1,2

  • 1Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore.

JAMA Network Open
|November 2, 2021
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

8.8K
Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development
12:53

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Published on: March 16, 2022

1.9K

Related Experiment Videos

Last Updated: Oct 14, 2025

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

10.5K
Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

8.8K
Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development
12:53

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Published on: March 16, 2022

1.9K

Related Concept Videos

Vaccinations01:51

Vaccinations

46.1K
Overview
46.1K

Articles linked to this work by shared authors, journal, and citation graph.

Targeted cleavage site mutations in the Gn precursor enable efficient generation of replication-competent rVSV-based surrogates for emerging nairoviruses.

Emerging microbes & infections·2026

Association of Plasma Biomarkers of Immunothrombosis With Death in Patients With Coronavirus Disease 2019 on Extracorporeal Membrane Oxygenation.

The Journal of infectious diseases·2026

Engineering HIV antibodies with enhanced breadth and potency of neutralization through multistate affinity maturation.

bioRxiv : the preprint server for biology·2025

Rapid, sensitive, and species-independent detection of Crimean Congo hemorrhagic fever virus nucleoprotein and GP38 antibodies.

EBioMedicine·2025

Precise targeting of HIV broadly neutralizing antibody precursors in humans.

Science (New York, N.Y.)·2025

A comprehensive engineering strategy improves potency and manufacturability of a near pan-neutralizing antibody against HIV.

Structure (London, England : 1993)·2025

A Hybrid Lifestyle Program and Metabolic Health in Adults With Obesity: The PRAMEV Randomized Clinical Trial.

JAMA network open·2026

Virtual Culturally Grounded Interventions for Substance Use in Urban American Indian and Alaska Native Emerging Adults: A Randomized Clinical Trial.

JAMA network open·2026

Contingency Management for Smoking Cessation Among Adults Experiencing Homelessness: A Pilot Randomized Clinical Trial.

JAMA network open·2026

Vertical Vaccination Against Infant Influenza Hospitalization in a Tropical Setting.

JAMA network open·2026

New Obesity Definition and Clinical Obesity Prevalence for Global Metabolic Bariatric Surgery.

JAMA network open·2026

Outcomes of Moderate-to-Severe Traumatic Brain Injury in a Low-Resource Setting.

JAMA network open·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us